The nutrient-sensing FXR-CREB axis, which closely modulates the autophagy network, may emerge as potential and new molecular targets for curing diseases involved in autophagy dysfunction and metabolic disorders, including NAFLD. The gene discussed is CREB1; the disease is metabolic dysfunction-associated steatotic liver disease.